Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVJF) Inventory Average (2016 - 2025)

Historic Inventory Average for Teva Pharmaceutical Industries (TEVJF) over the last 17 years, with Q4 2025 value amounting to $3.3 billion.

  • Teva Pharmaceutical Industries' Inventory Average fell 666.09% to $3.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year decrease of 666.09%. This contributed to the annual value of $3.1 billion for FY2025, which is 1198.06% down from last year.
  • As of Q4 2025, Teva Pharmaceutical Industries' Inventory Average stood at $3.3 billion, which was down 666.09% from $3.4 billion recorded in Q3 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Inventory Average registered a high of $4.4 billion during Q1 2021, and its lowest value of $1.9 billion during Q1 2024.
  • Moreover, its 5-year median value for Inventory Average was $3.9 billion (2024), whereas its average is $3.7 billion.
  • Data for Teva Pharmaceutical Industries' Inventory Average shows a peak YoY increase of 7843.24% (in 2024) and a maximum YoY decrease of 5218.21% (in 2024) over the last 5 years.
  • Teva Pharmaceutical Industries' Inventory Average (Quarter) stood at $4.0 billion in 2021, then dropped by 3.67% to $3.8 billion in 2022, then tumbled by 49.25% to $2.0 billion in 2023, then soared by 78.43% to $3.5 billion in 2024, then fell by 6.66% to $3.3 billion in 2025.
  • Its Inventory Average stands at $3.3 billion for Q4 2025, versus $3.4 billion for Q3 2025 and $3.4 billion for Q2 2025.